SUPERNUS PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.03 USD | -1.74% |
|
-3.07% | -6.05% |
| May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
| May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-21 | 2024-05-22 | 2024-05-23 | 2024-05-24 | 2024-05-28 | |
|---|---|---|---|---|---|
| Last | 28.05 $ | 27.87 $ | 27.77 $ | 27.51 $ | 27.19 $ |
| Volume | 706 784 | 966 793 | 623 542 | 453 220 | 219 619 |
| Change | -2.50% | -0.64% | -0.36% | -0.94% | -1.74% |
| Opening | 28.74 | 28.00 | 27.99 | 27.98 | 27.69 |
| High | 28.77 | 28.88 | 28.82 | 27.98 | 28.32 |
| Low | 27.63 | 27.78 | 27.52 | 27.12 | 27.12 |
Performance
| 1 day | -0.94% | ||
| 1 week | -4.38% | ||
| Current month | -8.60% | ||
| 1 month | -8.51% | ||
| 3 months | -10.36% | ||
| 6 months | +1.55% | ||
| Current year | -4.94% | ||
| 1 year | -18.17% | ||
| 3 years | -8.54% | ||
| 5 years | -18.12% | ||
| 10 years | +218.03% |
Volumes
marketsDaily volume
453 220
Estimated daily volume
453 220
Avg. Volume 20 sessions
661 578
Daily volume ratio
0.69
Avg. Volume 20 sessions USD
18 200 010.78
Record volume 1
11 208 680
Record volume 2
6 737 648
Record volume 3
6 644 855
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
1 512 341 727
Net sales (USD)
607 521 000
Number of employees
652
Sales / Employee (USD)
931 781
Free-Float
94.98 %
Free-Float capitalization (USD)
1 436 421 912
Average Daily Capital Traded
1.2%
Highs and lows
1 week
27.12
28.88
1 month
27.1232.87
Current year
26.2735.44
1 year
21.9935.96
3 years
21.9942.09
5 years
13.1242.09
10 years
7.3161.25
Indicators
Moving average 5 days
27.99
Moving average 20 days
29.59
Moving average 50 days
31.11
Moving average 100 days
29.98
Price spread / (MMA5)
+1.76%
Price spread / (MMA20)
+7.58%
Price spread / (MMA50)
+13.10%
Price spread / (MMA100)
+9.00%
STIM
RSI 9 days
30.15
RSI 14 days
35.25
Sector Comparison - Specialty & Advanced Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.94% | -4.38% | -4.94% | -18.17% | 1.51B | ||
| +0.04% | +0.94% | +16.07% | +1.39% | 79.03B | ||
| -0.31% | -0.62% | +8.65% | -3.27% | 8.78B | ||
| +0.48% | -6.36% | -16.43% | +16.04% | 4.83B | ||
| +0.67% | -3.87% | +48.34% | +98.81% | 4.65B | ||
| +1.14% | -7.45% | +2.91% | +24.94% | 3.89B | ||
| +1.69% | +2.53% | +14.90% | -6.81% | 2.34B | ||
| -0.97% | -5.90% | -26.94% | -46.66% | 2.18B | ||
| +0.80% | -3.39% | +16.55% | -6.93% | 2.11B | ||
| -2.13% | -8.82% | -36.25% | -48.28% | 2B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| +2.06% | -3.11% | -0.73% | -6.60% | 1.23B | ||
| +1.00% | +0.88% | -17.69% | -31.84% | 1.07B | ||
| -2.55% | -2.24% | -1.13% | +5.67% | 884M | ||
| -1.60% | -7.39% | +33.19% | +25.31% | 862M | ||
| +1.95% | +3.83% | +0.77% | +55.03% | 860M | ||
| Average | +0.08% | -2.83% | +2.48% | +3.91% | ||
| Weighted average by Cap. | +0.08% | -0.73% | +12.41% | +4.23% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
6ffdd4e48f7b2c49.bz2AkscR2mcMXoILSmAR2g7mlm_HI2ZCxsoOalGcM1E.B1TTwbFTqz4_ZrA8MlFThVyDwl-Paiggl7pjKDCpbBMEWuKnnnXtH0IV7Q
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 27.51 | 74,766 | 315,873 |
| 03:59:59 pm | 27.48 | 888 | 241,107 |
| 03:59:59 pm | 27.48 | 100 | 240,219 |
| 03:59:53 pm | 27.48 | 100 | 240,119 |
| 03:59:53 pm | 27.48 | 100 | 240,019 |
| 03:59:53 pm | 27.5 | 100 | 239,919 |
| 03:59:53 pm | 27.5 | 100 | 239,819 |
| 03:59:52 pm | 27.5 | 100 | 239,719 |
| 03:59:50 pm | 27.5 | 100 | 239,619 |
| 03:59:50 pm | 27.48 | 153 | 239,519 |
Monthly variations
Annual change
| 2024 | -4.94% | ||
| 2023 | -18.87% | ||
| 2022 | +22.33% | ||
| 2021 | +15.90% | ||
| 2020 | +6.07% | ||
| 2019 | -28.60% | ||
| 2018 | -16.64% | ||
| 2017 | +57.82% | ||
| 2016 | +87.87% | ||
| 2015 | +61.93% | ||
| 2014 | +10.08% | ||
| 2013 | +5.16% | ||
| 2012 | +33.52% |
- Stock Market
- Equities
- SUPN Stock
- Quotes Supernus Pharmaceuticals, Inc.
